Weuphoria Dosage/Direction for Use

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Thai FDA Category Presentation/Packing

The information highlighted (if any) are the most recent updates for this brand.

Full Prescribing Info

Dosage/Direction for Use

Since this product is a suspension containing an adjuvant, shake vigorously immediately prior to use to obtain a homogenous, white suspension in the vaccine container. This product is for intramuscular injection only. The preferred sites for injection are the anterolateral aspect of the thigh in infants and the deltoid muscle of the upper arm in toddlers and children. the vaccine should not be injected in and/or near the areas where nerve trunks and/or blood vessels may locate.
Vaccination schedules for infants and toddlers: The product is to be administered as a four-dose series at 2, 4, 6, and 12-15 months of age or 3, 4, 5, and 12-15 months of age, respectively, as described in Table 8 and Table 9. (See Tables 8 and 9.)

Click on icon to see table/diagram/image

Click on icon to see table/diagram/image

For children 7 months through 5 years of age who have not received the product, the catch-up schedule in Table 10 applies: See Table 10.

Click on icon to see table/diagram/image

Weuphoria Dosage/Direction for Use

vaccine, pneumococcal

Manufacturer:

Yuxi Walvax Biotechnology

Distributor:

Biovalys

Marketer:

Biovalys